Literature DB >> 28295273

Importance of Pain Acceptance in Relation to Headache Disability and Pain Interference in Women With Migraine and Overweight/Obesity.

Jason Lillis1, J Graham Thomas1, Elizabeth K Seng2, Richard B Lipton3, Jelena M Pavlović3, Lucille Rathier4, Julie Roth5, Kevin C O'Leary1, Dale S Bond1.   

Abstract

BACKGROUND: Pain acceptance involves willingness to experience pain and engaging in valued activities while pain is present. Though pain acceptance could limit both headache-related disability and pain interference in individuals with migraine, few studies have addressed this issue. This study evaluated whether higher levels of total pain acceptance and its two subcomponents, pain willingness and activity engagement, were associated with lower levels of headache-related impairment in women who had both migraine and overweight/obesity.
METHODS: In this cross-sectional study, participants seeking weight loss and headache relief in the Women's Health and Migraine trial completed baseline measures of pain acceptance (Chronic Pain Acceptance Questionnaire [CPAQ]), headache-related disability (Headache Impact Test-6), and pain interference (Brief Pain Inventory). Migraine headache frequency and pain intensity were assessed daily via smartphone diary. Using CPAQ total and subcomponent (pain willingness and activity engagement) scores, headache frequency, pain intensity, and body mass index (BMI) as predictors in linear regression, headache-related disability, and pain interference were modeled as outcomes.
RESULTS: On average, participants (n = 126; age = 38.5 ± 8.2 years; BMI = 35.3 ± 6.6 kg/m2 ) reported 8.4 ± 4.7 migraine days/month and pain intensity of 6.0 ± 1.5 on a 0-10 scale on headache days. After correcting for multiple comparisons (adjusted α = .008), pain willingness was independently associated with both lower headache-related disability (P < .001; β = -0.233) and pain interference (P < .001; β = -0.261). Activity engagement was not associated with headache-related disability (P = .128; β = -0.138) and pain interference (P = .042; β = -0.154). CPAQ total score was not associated with headache-related disability (P = .439; β = 0.066) and pain interference (P = .305; β = 0.074). Pain intensity was significantly associated with outcomes in all analyses (Ps < .001; βs 0.343-0.615).
CONCLUSIONS: Higher pain willingness, independent of degree of both migraine severity and overweight, is associated with lower headache-related disability and general pain interference in treatment-seeking women with migraine and overweight/obesity. Future studies are needed to clarify direction of causality and test whether strategies designed to help women increase pain willingness, or relinquish ineffective efforts to control pain, can improve functional outcomes in women who have migraine and overweight/obesity.
© 2017 American Headache Society.

Entities:  

Keywords:  acceptance; disability; headache; migraine; obesity; pain

Mesh:

Year:  2017        PMID: 28295273      PMCID: PMC5774226          DOI: 10.1111/head.13058

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  35 in total

1.  Two-factor learning theory: summary and comment.

Authors:  O H MOWRER
Journal:  Psychol Rev       Date:  1951-09       Impact factor: 8.934

2.  Triggers of migraine and tension-type headache.

Authors:  Christian Wöber; Ciçek Wöber-Bingöl
Journal:  Handb Clin Neurol       Date:  2010

Review 3.  The fear-avoidance model of musculoskeletal pain: current state of scientific evidence.

Authors:  Maaike Leeuw; Mariëlle E J B Goossens; Steven J Linton; Geert Crombez; Katja Boersma; Johan W S Vlaeyen
Journal:  J Behav Med       Date:  2006-12-20

4.  The Chronic Pain Acceptance Questionnaire: confirmatory factor analysis and identification of patient subgroups.

Authors:  Kevin E Vowles; Lance M McCracken; Charlotte McLeod; Christopher Eccleston
Journal:  Pain       Date:  2008-09-27       Impact factor: 6.961

5.  Cost and predictors of lost productive time in chronic migraine and episodic migraine: results from the American Migraine Prevalence and Prevention (AMPP) Study.

Authors:  Daniel Serrano; Aubrey N Manack; Michael L Reed; Dawn C Buse; Sepideh F Varon; Richard B Lipton
Journal:  Value Health       Date:  2013 Jan-Feb       Impact factor: 5.725

6.  Depression and disability in migraine: the role of pain acceptance and values-based action.

Authors:  Lilian Dindo; Ana Recober; James Marchman; Michael O'Hara; Carolyn Turvey
Journal:  Int J Behav Med       Date:  2015-02

7.  Body mass index and headaches: findings from a national sample of US adults.

Authors:  E S Ford; C Li; W S Pearson; G Zhao; T W Strine; A H Mokdad
Journal:  Cephalalgia       Date:  2008-08-22       Impact factor: 6.292

8.  Validation of the Brief Pain Inventory for chronic nonmalignant pain.

Authors:  Gabriel Tan; Mark P Jensen; John I Thornby; Bilal F Shanti
Journal:  J Pain       Date:  2004-03       Impact factor: 5.820

9.  Teaching acceptance and mindfulness to improve the lives of the obese: a preliminary test of a theoretical model.

Authors:  Jason Lillis; Steven C Hayes; Kara Bunting; Akihiko Masuda
Journal:  Ann Behav Med       Date:  2009-02-28

10.  Validation of the Headache Impact Test (HIT-6™) across episodic and chronic migraine.

Authors:  Min Yang; Regina Rendas-Baum; Sepideh F Varon; Mark Kosinski
Journal:  Cephalalgia       Date:  2010-09-06       Impact factor: 6.292

View more
  9 in total

1.  Acceptance, Psychiatric Symptoms, and Migraine Disability: An Observational Study in a Headache Center.

Authors:  Elizabeth K Seng; Alexander J Kuka; Sarah Jo Mayson; Todd A Smitherman; Dawn C Buse
Journal:  Headache       Date:  2018-06       Impact factor: 5.887

2.  Migraine disability, pain catastrophizing, and headache severity are associated with evoked pain and targeted by mind-body therapy.

Authors:  Samuel R Krimmel; Michael L Keaser; Darrah Speis; Jennifer A Haythornthwaite; David A Seminowicz
Journal:  Pain       Date:  2022-01-17       Impact factor: 7.926

3.  The Association of Changes in Pain Acceptance and Headache-Related Disability.

Authors:  Jason Lillis; J Graham Thomas; Richard B Lipton; Lucille Rathier; Julie Roth; Jelena Pavlovic; Kevin C O'Leary; Dale S Bond
Journal:  Ann Behav Med       Date:  2019-06-04

4.  Association between Body Mass Index and Migraine: A Survey of Adult Population in China.

Authors:  Qingqing Huang; Xiping Liang; Shiqiang Wang; Xiaosong Mu
Journal:  Behav Neurol       Date:  2018-04-19       Impact factor: 3.342

5.  Pain Acceptance and Its Associated Factors among Cancer Patients in Mainland China: A Cross-Sectional Study.

Authors:  Xianghua Xu; Meijun Ou; Chanjuan Xie; Qinqin Cheng; Yongyi Chen
Journal:  Pain Res Manag       Date:  2019-02-13       Impact factor: 3.037

6.  Pain interference type and level guide the assessment process in chronic pain: Categorizing pain patients entering tertiary pain treatment with the Brief Pain Inventory.

Authors:  Teemu Miettinen; Hannu Kautiainen; Pekka Mäntyselkä; Steven J Linton; Eija Kalso
Journal:  PLoS One       Date:  2019-08-20       Impact factor: 3.240

7.  Does sexual functioning improve with migraine improvements and/or weight loss?-A post hoc analysis in the Women's Health and Migraine (WHAM) trial.

Authors:  Leah Schumacher; Rena Wing; J Graham Thomas; Jelena Pavlovic; Kathleen Digre; Samantha Farris; Kristine Steffen; David Sarwer; Dale Bond
Journal:  Obes Sci Pract       Date:  2020-09-09

8.  Sensory processing patterns affect headache severity among adolescents with migraine.

Authors:  Jacob Genizi; Ayelet Halevy; Mitchell Schertz; Khaled Osman; Nurit Assaf; Idan Segal; Isaac Srugo; Aharon Kessel; Batya Engel-Yeger
Journal:  J Headache Pain       Date:  2020-05-06       Impact factor: 7.277

9.  Prevalence of migraine in Han Chinese of Fujian province: An epidemiological study.

Authors:  Qi-Fang Lin; Qiao-Qing Xia; Yu-Li Zeng; Xiao-Yang Wu; Lin-Feng Ye; Long-Teng Yao; Yong-Tong Xin; Gen-Bin Huang
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.